Novo Holdings A/S - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$92,044,178
+22.5%
3,377,7680.0%6.80%
+17.1%
Q2 2023$75,155,338
+2.7%
3,377,7680.0%5.81%
+20.3%
Q1 2023$73,162,455
+6.6%
3,377,7680.0%4.83%
+12.7%
Q4 2022$68,602,468
-19.6%
3,377,768
+1.5%
4.28%
+5.3%
Q3 2022$85,324,000
+42.0%
3,327,768
+31.7%
4.07%
+37.5%
Q2 2022$60,080,0002,526,4902.96%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders